| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.9B | $0.9B | $0.8B | $0.9B | $0.8B | $0.8B | $0.7B | $0.7B |
| Cost of Revenue | $0.4B | $0.3B | $0.3B | $0.3B | $0.4B | $0.3B | $0.3B | $0.3B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B |
| Operating Income | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B |
| Net Income | $0.6B | $0.6B | $0.6B | $0.7B | $0.7B | $0.5B | $0.6B | $0.6B |
| EPS (Basic) | $3.78 | $3.90 | $3.66 | $3.83 | $3.55 | $3.51 | $3.15 | $2.48 |
| EPS (Diluted) | $3.77 | $3.88 | $3.65 | $3.81 | $3.52 | $3.49 | $3.12 | $2.46 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.1B | $4.6B | $4.6B | $3.3B | $3.1B | $2.8B | $2.6B | $3.7B |
| Current Assets | $2.1B | $1.7B | $1.8B | $1.8B | $1.6B | $1.4B | $1.3B | $2.7B |
| Cash & Equivalents | $0.6B | $0.3B | $0.4B | $0.5B | $0.5B | $0.4B | $0.3B | $0.8B |
| Total Liabilities | $2.5B | $2.7B | $3.5B | $2.8B | $2.7B | $2.6B | $2.8B | $2.2B |
| Current Liabilities | $1.2B | $0.8B | $0.8B | $0.8B | $0.7B | $0.8B | $0.6B | $0.4B |
| Stockholders' Equity | $2.6B | $1.8B | $1.2B | $0.5B | $0.4B | $0.2B | $-0.2B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.8B | $0.6B | $0.6B | $0.7B | $0.8B | $0.6B | $0.6B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-1.4B | $-0.1B | $-0.2B | $-0.3B | $0.8B | $1.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $-0.7B | $0.8B | $-0.5B | $-0.4B | $-0.4B | $-1.9B | $-2.1B |